Amylyx Pharmaceuticals (AMLX) Short-term Investments (2021 - 2026)
Amylyx Pharmaceuticals (AMLX) reported Short-term Investments of $201.43 million for Q2 2026, up 64.1% from $122.74 million a year earlier and up 297.8% from the prior quarter.
Powered by 
Analysis
Amylyx Pharmaceuticals (AMLX) Short-term Investments (2021 - 2026) Analysis & Trends
At the end of FY2025, Amylyx Pharmaceuticals posted Short-term Investments of $90.33 million, down 8.9% from FY2024.
- Short-term Investments has declined for three consecutive years, though with a four-year compound annual growth rate of 18.4% (FY2021 to FY2025).
- By year, Short-term Investments came in at $99.11 million in FY2024 (-50.7%), $201.16 million in FY2023 (-29.3%), $284.42 million in FY2022 (+519.3%) and $45.93 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Short-term Investments since Q2 2024.
- Year over year, Short-term Investments gained in 1 of the last eight quarters, with an average decline of 23.7%.
- The high point for year-over-year Short-term Investments in five years was Q4 2022 (growth of 519.3%); the low point was Q1 2026 (a decline of 64.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $50.63 million (Q1 2026), $90.33 million (Q4 2025) and $118.81 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Amylyx Pharmaceuticals | 3.18 Bn | 1.99 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 201.43 Mn |
| Mar 31, 2026 | 50.63 Mn |
| Dec 31, 2025 | 90.33 Mn |
| Sep 30, 2025 | 118.81 Mn |
| Jun 30, 2025 | 122.74 Mn |
| Mar 31, 2025 | 144.30 Mn |
| Dec 31, 2024 | 99.11 Mn |
| Sep 30, 2024 | 162.56 Mn |
| Jun 30, 2024 | 234.81 Mn |
| Mar 31, 2024 | 202.74 Mn |
| Dec 31, 2023 | 201.16 Mn |
| Sep 30, 2023 | 219.79 Mn |
| Jun 30, 2023 | 109.52 Mn |
| Mar 31, 2023 | 231.11 Mn |
| Dec 31, 2022 | 284.42 Mn |
| Sep 30, 2022 | 54.86 Mn |
| Jun 30, 2022 | 139.24 Mn |
| Mar 31, 2022 | 144.80 Mn |
| Dec 31, 2021 | 45.93 Mn |
API Access
Amylyx Pharmaceuticals Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=AMLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "AMLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=AMLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();